Template:SUIT-038: Difference between revisions
From Bioblast
(Created page with "right|190px|link=http://www.bioblast.at/index.php/MitoPedia:_SUIT |MitoPedia: SUIT == Steps and respiratory states == File:1D;2M.1;2H2O;2c;3M.2;3M...") ย |
No edit summary |
||
Line 31: | Line 31: | ||
| 1D;2M.1;2H2O | | 1D;2M.1;2H2O | ||
* | * Titration of carrier (H2O) as a control, to be compared with protocols with titration of acylcarnitines to assess fatty acid oxidation-linked respiration. | ||
|- | |- | ||
Line 51: | Line 51: | ||
*Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | *Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | ||
*{{Template:SUIT OXPHOS}} ย | *{{Template:SUIT OXPHOS}} ย | ||
Line 62: | Line 61: | ||
*Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | *Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | ||
*{{Template:SUIT OXPHOS}} ย | *{{Template:SUIT OXPHOS}} ย | ||
Line 73: | Line 71: | ||
*Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | *Malate kinetics in the presence of saturating [ADP] allows the evaluation of malate anaplerotic pathways. | ||
*{{Template:SUIT OXPHOS}} ย | *{{Template:SUIT OXPHOS}} ย | ||
Revision as of 13:55, 12 April 2023
Steps and respiratory states
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M) |
---|---|---|---|---|
1D | ROX | 1D
| ||
2M.1 | 1D;2M.1 | |||
2H2O | 1D;2M.1;2H2O
| |||
3c | 1D;2M.1;2H2O;2c
| |||
3M.2 | 1D;2M.1;2H2O;2c;3M.2
| |||
3M.5 | 1D;2M.1;2H2O;2c;3M.2;3M.5
| |||
3M1 | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1
| |||
3M2 | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2
| |||
4P | PMP | N | CI | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P
|
5G | PGMP | N | CI | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G
|
6S10 | PGMSP | NS | CI&II | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10
|
6S50 | PGMSP | NS | CI&II | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50
|
7Gp | PGMSGpP | NSGp | CI&II&GpDH | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp
|
8U | PGMSGpE | NSGp | CI&II&GpDH | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp;8U
|
9Rot | SGpE | SGp | CII&GpDH | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp;8U;9Rot
|
10Ama | ROX | 1D;2M.1;2H2O;2c;3M.2;3M.5;3M1;3M2;4P;5G;6S10;6S50;7Gp;8U;9Rot;10Ama
|
- Bioblast links: SUIT protocols - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>
- Coupling control
- Pathway control
- ยป Electron transfer pathway
- ยป Fatty acid oxidation pathway control state, F
- ยป NADH electron transfer-pathway state, N
- ยป Succinate pathway control state, S
- ยป NS-pathway control state, NS
- ยป Glycerophosphate pathway control state, Gp
- ยป Complex IV single step, CIV
- ยป Anaplerotic pathway control state
- Pathway control
- Main fuel substrates
- ยป Glutamate, G
- ยป Glycerophosphate, Gp
- ยป Malate, M
- ยป Octanoylcarnitine, Oct
- ยป Pyruvate, P
- ยป Succinate, S
- Main fuel substrates
- Glossary